Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
1 clinical trials · Condition
◉ Watch Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
| Record | Firm | Date |
|---|---|---|
| Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus. (NCT07203664) | Hospital Universitario La Paz | 2025-10-30 |
Track Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients automatically
Every clearance here is in the API, with alerts when new ones post.